Kura Oncology, Inc.
KURA
$8.58
-$0.15-1.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.24% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.24% | -- | -- | -- | -- |
| Cost of Revenue | 47.75% | 2.57% | 11.24% | 25.19% | 47.50% |
| Gross Profit | -58.20% | 42.09% | 32.31% | 19.68% | -0.74% |
| SG&A Expenses | 55.60% | 55.96% | 45.02% | 42.49% | 52.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.20% | 58.09% | 51.42% | 47.77% | 49.02% |
| Operating Income | -57.16% | -10.26% | -9.80% | -10.75% | -16.52% |
| Income Before Tax | -61.88% | -8.65% | -7.25% | -6.88% | -12.67% |
| Income Tax Expenses | -85.28% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.17% | -9.79% | -8.49% | -8.21% | -13.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.17% | -9.79% | -8.49% | -8.21% | -13.99% |
| EBIT | -57.16% | -10.26% | -9.80% | -10.75% | -16.52% |
| EBITDA | -57.32% | -10.31% | -9.84% | -10.82% | -16.61% |
| EPS Basic | -57.04% | -5.18% | -1.26% | 3.95% | 2.90% |
| Normalized Basic EPS | -52.05% | -5.06% | -1.33% | 3.60% | 2.48% |
| EPS Diluted | -57.04% | -5.18% | -1.26% | 3.95% | 2.90% |
| Normalized Diluted EPS | -52.05% | -5.06% | -1.33% | 3.60% | 2.48% |
| Average Basic Shares Outstanding | 1.76% | 4.47% | 7.37% | 12.93% | 17.71% |
| Average Diluted Shares Outstanding | 1.76% | 4.47% | 7.37% | 12.93% | 17.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |